Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRS vs GSK✓SelectedUSD · GSKCRS vs GSK performance historyLatest closeAs of-4.43%11/16
Stock and ETF performance explorer

CRS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+804.4%
GSK return
+46.9%
Excess return
+757.5%
Maximum drawdown
-55.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.4%-0.1%-4.3%-4.4%
7D-8.7%-1.3%-7.4%-8.5%
30D-26.1%+2.7%-28.8%-26.6%
3M-48.8%+2.7%-51.5%-49.3%
6M-31.8%+3.3%-35.1%-32.7%
YTD-11.3%+6.5%-17.8%-12.7%
1Y-15.5%+10.7%-26.2%-17.5%
3Y+322.5%+64.4%+258.1%+263.5%
5Y+804.4%+46.7%+757.7%+626.2%
All+804.4%+46.9%+757.5%+626.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling